Tags: Drug.

Laropiprant (INN) is used in combination with niacin to reduce blood cholesterol (LDL and VLDL). Merck & Co. planned to market this combination under the trade names Cordaptive in the US and Tredaptive in Europe. Both brands contain 1000 mg of niacin and 20 mg of laropiprant in each tablet. Laropiprant itself has no cholesterol lowering effect but it reduces facial flushes induced by niacin.

Laropiprant.png
ATC prefix
none, C10
ATC suffix
AD52
CAS number
571170-77-9
FDA UNII code
G7N11T8O78
IUPAC name
(-)-[(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1234-tetrahydrocyclopenta[b]indol-3-yl]acetic acid
PubChem
11948701, 9867642

Loading...

This page contains content from the copyrighted Wikipedia article "Laropiprant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.